Articles

This podcast series details the ins and outs of managing, preventing, and treating HIV, from the perspective of the faculty and patients of the UNC Institute for Global Health & Infectious Diseases.

UNC Global Health Podcast Series: HIV Matters

Misinformation about clinical research, mistrust between scientists and the community, and HIV-related stigma often impede efforts to find an HIV cure.

Crowdsourcing Brings Researchers and the Community Together to Cure HIV

Videos

The fight against the acquired immunodeficiency syndrome (AIDS) epidemic has made huge strides in recent years, but there is still much more work to be done. What role technology will play in that effort has yet to be determined.

Technology's Role in the Future of AIDS Care

There are several areas of the country where the acquired immunodeficiency syndrome (AIDS) epidemic remains to be a problem. Both minorities and those in the southern states are seeing a continued problem with the disease, while the northern states are seeing improvements in numbers.

Reaching at Risk Patients in AIDS Care and Prevention

As the battle against the acquired immunodeficiency syndrome (AIDS_ epidemic continues, a project funded by the National Institutes of Health (NIH) is looking at different ways to use technology to help in the prevention and care of the human immunodeficiency virus (HIV) and AIDS.

NIH-Funded Project Looks at Ways to Use Technology in AIDS Prevention and Care

Although prenatal human immunodeficiency virus (HIV) transmission has declined by 90% since the early 1990s, the need for studies focusing are pregnant women with HIV are very much needed.

Major Gaps in HIV Research Leave Pregnant Women at Risk

Untreated pregnant women with the human immunodeficiency virus (HIV) will transmit the infection to their child up to 45% of the time. But a new anti-HIV medication could lower that percentage.

Potential HIV Medication Protects Mother-to-Child Transmission

Researchers from the University of North Carolina (UNC) analyzed how the human immunodeficiency virus (HIV) attacks macrophages â€“ a target that, up until now, was believed to have little to do with infection.

The HIV Target That We're Not Talking About

Pre-clinical study results appear to demonstrate the efficacy of a new long-acting formulation of the HIV medication raltegravir in preventing vaginal transmission of HIV in animal models.

Long-Acting Raltegravir Prevents Vaginal HIV Transmission

If research continues focusing on macrophages and their role in the human immunodeficiency virus (HIV), it could mean new opportunities to treat patients and eventually help find a cure.

Jenna Honeycutt from the University of North Carolina: Learning From Macrophages to Help Fight HIV

About the Institute for Global Health & Infectious Diseases

Institute for Global Health & Infectious Diseases

 (IGHID) brings transformative solutions to the most important global health issues of our time, through research, training and service. The IGHID has saved millions of lives and shaped policy worldwide through cutting-edge research, especially in the areas of HIV, Malaria and now COVID, where UNC is the most cited university in the nation for coronavirus research. Working in over 50 countries around the globe, the IGHID provides a unique pan-university framework for collaboration and facilitating global health science and practice. It is this framework that continues to catalyze a global health community committed to improving health worldwide while building the capacity of thousands of scientists and health professionals globally.

UNC Institute for Global Health & Infectious Diseases

Latest News